Affibody’s Albumod™ platform is protected by separate Affibody intellectual property rights and represents an opportunity to:

• develop novel biopharmaceuticals
• develop line extensions with improved properties

The Albumod™ platform is available for out-licensing on a non-exclusive basis. Please contact bd@affibody.com for more information.